Amanote Research
Register
Sign In
Systematic Review of the Efficacy and Safety of Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: Identification of the Relevant Clinical Trials
Value in Health
- United Kingdom
doi 10.1016/j.jval.2016.03.1649
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
May 1, 2016
Authors
GH Lyman
D King
O Evuarherhe
D Powers
B Harrow
Publisher
Elsevier BV
Related search
Evolving Role of Neurokinin 1-Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting
OncoTargets and Therapy
Oncology
Pharmacology
Neurokinin-1 Receptor Antagonists: Review of Their Role for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Adults
Expert Review of Clinical Pharmacology
Medicine
Toxicology
Pharmaceutics
Pharmacology
Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting: Approval and Efficacy
Cancer Management and Research
Oncology
Cannabinoids for Control of Chemotherapy Induced Nausea and Vomiting: Quantitative Systematic
BMJ
Corticosteroids in the Treatment of Chemotherapy-Induced Nausea and Vomiting
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting
Malignant tumours
Review: Cannabinoids Control Chemotherapy-Induced Nausea and Vomiting but Increase the Risk of Side Effects
Evidence-Based Medicine
Medicine
Granisetron Transdermal System in the Management of Chemotherapy-Induced Nausea and Vomiting
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
Dronabinol for Chemotherapy-Induced Nausea and Vomiting Unresponsive to Antiemetics
Cancer Management and Research
Oncology
